Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|June 23, 1998
Paclitaxel plus ifosfamide in advanced ovarian cancer: results of a phase I studyU Klaassen, A Harstrick, D Strumberg, et al.
Anti-Cancer Drugs|June 1, 1996
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell linesD Strumberg, A Harstrick, K Doll, et al.
International Journal of Oncology|May 17, 2011
Treatment of adult osteosarcoma - single-center results in 47 patientsC Bokemeyer, H Schmoll, A Harstrick, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell linesA Harstrick, H J Schmoll, G Sass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)U Vanhoefer, S Cao, A Harstrick, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Activity of cytostatic drugs in two heterotransplanted human testicular cancer cell lines with different sensitivity to standard agentsA Harstrick, H J Schmoll, J Casper, et al.
Journal of Clinical Apheresis|August 10, 1999
Thrombopoietin serum levels at the start of mobilization, collection, and transfusion of autologous peripheral blood stem cellsP Bojko, N Nowak, T Moritz, et al.
Seminars in Oncology|November 28, 1997
Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II studyU Klaassen, H Wilke, C Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic OncologyJ Pont, C Bokemeyer, A Harstrick, et al.
Seminars in Oncology|April 1, 1992
Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trialsC H Köhne-Wömpner, H J Schmoll, A Harstrick, et al.
Pageof 9